hepatitis b

Agenix Sells HBV Drug To Cinkate For USD$2 Million

With the sale of its patented hepatitis drug AGX-1009 to Cintake, Agenix has exited all operations in China.

Cost Effective To Track Hepatitis B Carriers

A study has determined that monitoring inactive chronic hepatitis B carriers is a cost-effective strategy for managing the disease in China.

Men-Only Hepatitis B Mutation Explains Higher Cancer Rates

A mutation in the hepatitis B virus (HBV) that appears only in men could explain why HBV-infected men have much higher liver cancer rates.

WHO Urges Action On Hepatitis Threat

The World Health Organization has urged governments to act against the five hepatitis viruses that can cause severe liver infections.

Chinese Academics Unveil Their Top 10 Innovations Of 2012

Academics at the Chinese Academy of Sciences and Chinese Academy of Engineering have voted in their top 10 scientific innovations of 2012.

Immune Gene Linked To Control Of HIV Virus

A gene that is essential for embryo survival could also be the key to treating chronic infections such as HIV.

PerkinElmer Acquires Chinese Infectious Disease Diagnostics Company

PerkinElmer has acquired Shanghai Haoyuan Biotech to extend its reach into the growing Chinese nucleic acid-based blood screening market.

Earlier Hepatitis B Treatment In Young Patients May Yield Better Results

Scientists in Singapore have found that young patients with Hepatitis B are not immune tolerant as previously thought.

Bristol-Myers Squibb Awards Four Grants For Hepatitis Education

To mark World Hepatitis Day 2012, the Bristol-Myers Squibb Foundation has awarded four new grants focused on Hepatitis B and Hepatitis C research in China and India.